-
Dr. Litao Zhang Interprets Wuhan Asia General Hospital’s Innovative Anticoagulation Research
From June 22 to June 26, 2024, the 32nd International Society on Thrombosis and Haemostasis (ISTH 2024) conference was successfully held in Bangkok, Thailand. At this prestigious event, the research achievements of Dr. Litao Zhang’s team from Wuhan Asia General Hospital shone brightly. Several studies on anticoagulation management were selected, showcasing their significant contributions and…
-
BOC/BOA 2024 | Dr. Ye Guo Shares Advances in Head and Neck Tumor Research and Benefits of Personalized Treatment
Head and neck tumors are common malignant tumors among Chinese residents, significantly impacting organ function, quality of life, and prognosis due to disease progression and treatment effects. The “2024 Annual Progress in Clinical Oncology Conference (BOC) and Best of ASCO 2024 China” was recently held in Guangzhou, showcasing the progress of clinical oncology research in…
-
The visit of Dr. Tao Cheng, President of the Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences
From July 11 to 12, Dr. Tao Cheng, President of the Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences (IHCAMS), and his delegation visited Thailand. They met with representatives from the Ministry of Public Health of Thailand, the Embassy of The People’s Republic of China in the Kingdom of Thailand ,…
-
BOC/BOA 2024 | Dr. Zhitao Ying: Annual Advances in Chinese Clinical Oncology 2023 ——Lymphoma)
Since 2015, the Chinese Society of Clinical Oncology (CSCO) has been dedicated to presenting annual reports on the progress of clinical oncology in China, under the theme “International Standards, Chinese Characteristics, Learning and Innovation.” At the recent “2024 Annual Progress in Chinese Clinical Oncology Conference (BOC) and Best of ASCO 2024 China,” the latest “Annual…
-
Dr. Huiqiang Huang: Advances in Clinical Immunotherapy for Lymphoma, Highlighting PD-1/PD-L1 Antibody Combination Therapies
In the realm of immunotherapy for lymphoma, PD-1/PD-L1 antibody combination therapies have emerged as a prominent area of research due to their precise modulation of the immune response. These therapies hold immense potential for enhancing efficacy and ensuring safety, providing lymphoma patients with more treatment options and the possibility of improved quality of life and…
-
Dr. Zhangyin Ming: TGF-β1 Released by Platelets Promotes Tumor Cell Autophagy, Mediates Epithelial-Mesenchymal Transition, and Tumor Metastasis
From June 22 to June 26, 2024, the 32nd International Society on Thrombosis and Haemostasis (ISTH 2024) conference was successfully held in Bangkok, Thailand. At this year’s conference, a study by Dr. Zhangyin Ming’s team from the School of Basic Medicine, Tongji Hospital of Huazhong University of Science and Technology, explored “The Role of Platelets…
-
EHA Expert Interview | Dr. Sizhou Feng: Insights from Resistant Bacterial Colonization in Hematology Patients for Empirical Therapy
Patients undergoing hematopoietic stem cell transplantation and high-dose chemotherapy for hematological diseases have impaired immune function, making them highly susceptible to febrile neutropenia and colonization or infection with resistant bacteria. Prompt and accurate initiation of empirical therapy is crucial to improve patient outcomes. At the 2024 European Hematology Association (EHA) Annual Meeting, Dr. Sizhou Feng’s…
-
Epigenetic Changes and Chromatin Architecture in Lipid Metabolic Reprogramming During Trastuzumab Adaptation in HER2-Positive Breast Cancer
In a significant advancement in breast cancer research, Dr. Yongmei Yin and her team from The First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital published the article “Unveiling Alterations of Epigenetic Modifications and Chromatin Architecture Leading to Lipid Metabolic Reprogramming during the Evolutionary Trastuzumab Adaptation of HER2-Positive Breast Cancer” in Advanced Science on…
Connecting Medical Expertise through Media